Loading...
Regional Anticoagulant Adoption Will Drive Long Term Opportunity In Renal Replacement Therapy
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
1Y
65.6%7D
12.4%1Y
65.6%7D
12.4%You can edit this narrative until Dec 16 7:05 AM. Then, changes will post as Updates.
Author's Valuation
US$3.2575.0% undervalued intrinsic discount
AnalystConsensusTarget Fair Value